CAM
MRNA icon

Carret Asset Management’s Moderna MRNA Stock Holding History

Carret Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,500
Closed -$269K – 276
2022
Q4 		$269K Buy
+1,500
New +$245K 0.04% 228
2022
Q3 		– Sell
-1,500
Closed -$214K – 272
2022
Q2 		$214K Hold
1,500
– – 0.03% 263
2022
Q1 		$258K Hold
1,500
– – 0.03% 259
2021
Q4 		$381K Hold
1,500
– – 0.04% 217
2021
Q3 		$577K Hold
1,500
– – 0.07% 184
2021
Q2 		$352K Buy
+1,500
New +$268K 0.04% 224

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Carret Asset Management's MRNA Position: Q1 2023 in Review

Carret Asset Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,500 shares — an estimated $269K sold.

Carret Asset Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $577K in Q3 2021. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Carret Asset Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Carret Asset Management sold 1,500 Moderna shares in Q1 2023, an estimated $269K.
  • Carret Asset Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
  • Carret Asset Management's Moderna position peaked at $577K in Q3 2021.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Carret Asset Management's 13F filing for Q1 2023, filed 11 May 2023.